2025 HCPCS Modifiers J3
Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology
TAGS: competitive average sales acquisition program reimbursed through available methodology price| Short Description | Cap drug unavail thru cap |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2006 |
| HCPCS Action Effective Date | January 01, 2006 |
Check Similar Modifiers
- J1 - Cap no-pay for prescript num
- J2 - Cap restock of emerg drugs
- J3 - Cap drug unavail thru cap
- J4 - Dmepos comp bid furn by hosp
- J5 - Dmepos comp bid fur by pt/ot
- JA - Administered intravenously
- JB - Administered subcutaneously
- JC - Skin substitute graft
- JD - Skin sub not used as a graft
- JE - Administered via dialysate
- JF - Compounded drug
- JG - 340b acquired drug
- JK - Drug supply 1 month or less
- JL - Drug 3 month supply
- JW - Discarded drug not administe
- JZ - Zero drug wasted